uniQure N.V. (NASDAQ: QURE)
$8.96
-0.1550 ( -1.70% ) 654.0K
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$8.96
Previous close
$9.11
Volume
654.0K
Market cap
$433.55M
Day range
$8.91 - $9.41
52 week range
$3.73 - $11.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
8-k | 8K-related | 16 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
10-k | Annual reports | 125 | Feb 28, 2024 |
5 | Other | 1 | Feb 06, 2024 |